← All stocks

Medpace Holdings, Inc.

MEDP Net selling
CIK 0001668397 #724 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$31.02M
$0.00 on a plan · $2.38M straight out of an exercise
Sold at will
$28.63M
7 of 8 sales
Net
−$31.02M
−$28.63M against sales at will

By person

9 insiders · 9 transactions
3,478×

August J. Troendle holds 3,478 times base salary in stock. $3.26B of shares against $937.42K in salary for 2025.

Salary from the company's own proxy. The shares are what August J. Troendle last reported holding, valued at $621.29, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Troendle August J.
President & CEO
$28.63M (7)
−$28.63M
5,248,172
18.80%
$3.26B
−2.6%
Kraft Robert O.
Director
$2.38M (1) scheduled
−$2.38M
955
0.0034%
$593.33K
+83.7%
BURWIG SUSAN E
Exec. VP, Operations
65,984
0.2364%
$41.00M
+14.8%
Carley Brian T
Director
27,825
0.0997%
$17.29M
+27.9%
EWALD STEPHEN P
General Counsel & Corp. Secy.
20,343
0.0729%
$12.64M
+52.5%
GEIGER JESSE J
President
15,000
0.0537%
$9.32M
−30.2%
Brady Kevin M.
CFO & Treasurer
12,830
0.0460%
$7.97M
+113.8%
McCarthy Cornelius P. III
Director
12,275
0.0440%
$7.63M
+137.7%
DAVENPORT FRED B JR
Director
3,798
0.0136%
$2.36M
Insider
Date
Role
Action
Shares
Price
Amount
Troendle August J.
16 Sep 2026
President & CEO
Sell
8,770
$621.29
$5.45M
Troendle August J.
15 Sep 2026
President & CEO
Sell
15,971
$620.84
$9.92M
Troendle August J.
27 Aug 2026
President & CEO
Sell
650
$620.27
$403.18K
Troendle August J.
26 Aug 2026
President & CEO
Sell
4,000
$620.03
$2.48M
Troendle August J.
25 Aug 2026
President & CEO
Sell
673
$620.38
$417.52K
Troendle August J.
24 Aug 2026
President & CEO
Sell
1,983
$620.23
$1.23M
Troendle August J.
21 Aug 2026
President & CEO
Sell
13,995
$624.45
$8.74M

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 6,858
History held since 3 Nov 2016